Amniotic Membrane Market continues to expand with Membrane Applications and Development Activities

Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids.

Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/4477

According to a study published by the National Center for Biotechnology Information (NCBI) in February 2021, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.

Rising number of ophthalmology surgeries in geriatric population is expected to drive growth of the global amniotic membrane market during the forecast period. For instance, according to the Centers for Medicare and Medicaid Services (CMS), in 2017, over 50.7 million people in the U.S. were above 65 years of age meanwhile the total number of glaucoma surgeries performed were approximately 174,788. Amniotic membrane transplantation is used in glaucoma surgeries to prevent inflammation as these membranes lack immunogenicity and cannot be recognized by the immune system of human body. Hence, growing number of glaucoma surgeries is expected to fuel the growth of amniotic membrane market.

Market players are engaged in inorganic activities such as partnership, merger and acquisitions, this is expected to drive growth of the amniotic membrane market. For instance, in November 2018, Generex Biotechnology Corporation, a biotechnology company, acquired 51% stakes of Olaregen Therapeutix Inc., a regenerative medicine company based in New York, this acquisition is expected to help the company to expand its product portfolio.

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/4477

Major players operating in the global amniotic membrane market include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

𝗔𝗯𝗼𝘂𝘁 𝗖𝗼𝗵𝗲𝗿𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:-
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.